SUPPORTIVE CARE IN CANCER, vol.22, no.2, pp.445-451, 2014 (SCI-Expanded)
Adjuvant chemoradiotherapy (CRT) improves the survival in patients with locally advanced stomach cancer. The kidneys are the major dose-limiting organs for radiotherapy (RT) in upper abdominal cancers. We aimed to evaluate the impact of adjuvant CRT on renal function of patients with stomach cancer.